Dactylosporangium sp. (ATCC® 53693)

Strain Designations: SC 14051  /  Type Strain: no  /  Biosafety Level: 1

Strain Designations SC 14051
Application
Produces dactylocycline A
Produces dactylocycline B
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Preceptrol® no
Type Strain no
Medium ATCC® Medium 196: Yeast malt extract agar
Growth Conditions
Temperature: 26.0°C
Name of Depositor E.R. Squibb & Sons, Inc.
U.S. Patent Number
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
References

Wells JS, et al. Dactylocyclines, novel tetracycline derivatives produced by a Dactylosporangium sp. I. Taxonomy, production, isolation and biological activity. J. Antibiot. 45: 1892-1898, 1992. PubMed: 1490880

Tymiak AA, et al. Dactylocyclines, novel tetracycline derivatives produced by a Dactylosporangium sp. II. Structure elucidation. J. Antibiot. 45: 1899-1906, 1992. PubMed: 1490881

Devasthale PV, et al. Dactylocyclines, novel tetracycline derivatives produced by a Dactylosporangium sp. III. Absolute stereochemistry of the dactylocyclines. J. Antibiot. 45: 1907-1913, 1992. PubMed: 1490882